Buxly Paints Limited (PSX:BUXL)
184.17
+2.52 (1.39%)
At close: Aug 1, 2025
CTI BioPharma Balance Sheet
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2016 - 2020 |
Cash & Equivalents | 51.11 | 49.17 | 43.26 | 29.72 | 20.03 | 10.86 | Upgrade |
Cash & Short-Term Investments | 51.26 | 49.17 | 43.26 | 29.72 | 20.03 | 10.86 | Upgrade |
Cash Growth | 11.43% | 13.67% | 45.58% | 48.33% | 84.49% | -40.61% | Upgrade |
Accounts Receivable | 254.24 | 217.75 | 160.68 | 158.85 | 116.45 | 79.24 | Upgrade |
Other Receivables | 20.28 | 10.47 | 6.43 | 3.12 | 6 | 8.2 | Upgrade |
Receivables | 275.22 | 228.86 | 167.69 | 162.51 | 122.69 | 87.83 | Upgrade |
Inventory | 94.71 | 80.16 | 81.6 | 99.88 | 100.91 | 72.24 | Upgrade |
Prepaid Expenses | 0.16 | 0.32 | 0.07 | 0.47 | 0.36 | 0.21 | Upgrade |
Other Current Assets | 3.43 | 2.95 | 6.41 | 12.55 | 12.47 | 10.78 | Upgrade |
Total Current Assets | 424.77 | 361.46 | 299.03 | 305.13 | 256.46 | 181.91 | Upgrade |
Property, Plant & Equipment | 171.29 | 171.29 | 171.46 | 133.28 | 131.6 | 131.55 | Upgrade |
Other Long-Term Assets | 16.84 | 15.6 | 13.95 | 12.31 | 10.46 | 8.84 | Upgrade |
Total Assets | 621.8 | 556.89 | 490.31 | 454.99 | 399.88 | 324.62 | Upgrade |
Accounts Payable | 328.22 | 264.64 | 251.8 | 259.07 | 180.93 | 139.26 | Upgrade |
Accrued Expenses | 1.49 | 10.65 | 8.46 | 5.05 | 4.09 | 3.93 | Upgrade |
Short-Term Debt | 103.37 | 87.76 | 43.47 | 44.46 | 73.89 | 45.88 | Upgrade |
Current Portion of Long-Term Debt | - | - | - | 1.05 | 2.09 | 0.46 | Upgrade |
Current Portion of Leases | 0.39 | 0.44 | 0.34 | 0.32 | - | - | Upgrade |
Current Unearned Revenue | - | 2.45 | 2.45 | 2.45 | 1.21 | 0.17 | Upgrade |
Other Current Liabilities | 0.32 | 3.02 | 2.43 | 2.21 | 1.75 | 1.43 | Upgrade |
Total Current Liabilities | 433.78 | 368.96 | 308.95 | 314.59 | 263.96 | 191.13 | Upgrade |
Long-Term Debt | - | - | - | - | 1.05 | 1.39 | Upgrade |
Long-Term Leases | 0.26 | 0.54 | 0.98 | 1.31 | - | - | Upgrade |
Total Liabilities | 434.04 | 369.5 | 309.93 | 315.9 | 265.01 | 192.52 | Upgrade |
Common Stock | 14.4 | 14.4 | 14.4 | 14.4 | 14.4 | 14.4 | Upgrade |
Retained Earnings | 4.42 | 4.05 | -2.95 | -5.67 | -9.88 | -12.65 | Upgrade |
Comprehensive Income & Other | 168.93 | 168.93 | 168.93 | 130.35 | 130.35 | 130.35 | Upgrade |
Shareholders' Equity | 187.76 | 187.39 | 180.38 | 139.08 | 134.87 | 132.11 | Upgrade |
Total Liabilities & Equity | 621.8 | 556.89 | 490.31 | 454.99 | 399.88 | 324.62 | Upgrade |
Total Debt | 104.01 | 88.74 | 44.79 | 47.13 | 77.02 | 47.73 | Upgrade |
Net Cash (Debt) | -52.76 | -39.56 | -1.53 | -17.41 | -56.99 | -36.87 | Upgrade |
Net Cash Per Share | -36.74 | -27.47 | -1.06 | -12.09 | -39.58 | -25.60 | Upgrade |
Filing Date Shares Outstanding | 1.44 | 1.44 | 1.44 | 1.44 | 1.44 | 1.44 | Upgrade |
Total Common Shares Outstanding | 1.44 | 1.44 | 1.44 | 1.44 | 1.44 | 1.44 | Upgrade |
Working Capital | -9 | -7.5 | -9.92 | -9.46 | -7.5 | -9.22 | Upgrade |
Book Value Per Share | 130.39 | 130.13 | 125.27 | 96.59 | 93.66 | 91.74 | Upgrade |
Tangible Book Value | 187.76 | 187.39 | 180.38 | 139.08 | 134.87 | 132.11 | Upgrade |
Tangible Book Value Per Share | 130.39 | 130.13 | 125.27 | 96.59 | 93.66 | 91.74 | Upgrade |
Land | - | 169.77 | 169.77 | 131.19 | 131.19 | 131.19 | Upgrade |
Machinery | - | 2.74 | 2.58 | 4.62 | 2.54 | 2.42 | Upgrade |
Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.